• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

One Health High-Level Expert Panel Opinon - Prevention of zoonotic spillover

Mary Wilson

Well-known member
FROM RELYING ON RESPONSE TO REDUCING
THE RISK AT SOURCE OHHLEP whitepaper/Opinion piece

Authored by the members of the One Health High-Level Expert Panel (OHHLEP):

Wanda Markotter*, Thomas C. Mettenleiter*, Wiku B. Adisasmito, Salama Almuhairi, Casey Barton Behravesh, Pépé Bilivogui, Salome A. Bukachi, Natalia Casas, Natalia Cediel Becerra, Dominique F. Charron, Abhishek Chaudhary, Janice R. Ciacci Zanella, Andrew A. Cunningham Osman Dar, Nitish Debnath, Baptiste Dungu, Elmoubasher Farag, George F. Gao, David T. S. Hayman, Margaret Khaitsa, Marion P. G. Koopmans, Catherine Machalaba, John S. Mackenzie, Serge Morand, Vyacheslav Smolenskiy, Lei Zhou
*Corresponding authors

BACKGROUND AND CONTEXT

The devastating impact of COVID-19 on human health globally has prompted extensive discussions on how to better prepare for and safeguard against the next pandemic. Zoonotic spillover of pathogens from animals to humans is recognised as the predominant cause of emerging infectious diseases and as the primary cause of recent pandemics [1]. This spillover risk is increased by a range of factors (called drivers) that impact the nature, frequency and intensity of contact between humans and wild animals. Many of these drivers are related to human impact, for instance, deforestation and changes in land use and agricultural practices. While it is clear that the triad of prevention-preparedness-response (P-P-R) is highly relevant, there is much discussion on which of these three strategic activities in the eld of emerging infectious disease should be prioritized and how to optimally target resources. For this, it is important to understand the scope of the respective activity and the consequences of prioritization. Already, the Pandemic Fund and forthcoming global Pandemic instrument appear primarily focused on the early detection, and reaction to the appearance of human illnesses, often with explicit focus only on action to be taken once pathogen spillover and spread have occurred. Strategies to reduce the probability of spillover events are under-prioritised and under-utilized, as highlighted by recent infectious disease crises such as Ebola and Mpox epidemics, and have been lost in overall preparedness discussions and recovery nancing. This ‘more of the same’ focus suggests that it is politically more expedient to allocate nancial resources to deal with a problem once it has arisen, rather than taking the steps necessary to reduce the risk of it occurring in the first place. ...

https://cdn.who.int/media/docs/defa...spillover.pdf?sfvrsn=652707eb_1&download=true
 
Back
Top